MarketResearchTrends

Lice Treatment Market Lice are parasites that grow mostly in the head or pubic areas and feed on human blood. These parasites are increasingly becoming resistant to traditional methods of treatments which has created an urgent need for the development of effective treatment options. The lice treatment market size is projected to grow USD 0.167 billion by 2030, at CAGR 7.65% during the forecast period The prevalence of lice parasites contamination is increasing perpetually worldwide which is the prime factor boosting the growth of the lice treatment market. New product launches, elevation in level of awareness, and easy availability of lice treatment products is fueling the growth of the market. Growing R&D activities by pharmaceutical companies to come up effective compounds which can effective kill these more than ever resistant parasites is likely to provide attractive opportunities to the market. They don't transmit infections like head lice are well-known for doi...

Narcolepsy Market Increasing prevalence of narcolepsy , growing the obese population, increasing demands for effective treatment, rising research and development are estimated to be some of the significant drivers for the global narcolepsy market. Narcolepsy Market is expected to register a CAGR of 9.7 % with USD 6.9 Billion by 2030 Various factors are adding to the global narcolepsy market share. These factors, as per the new MRFR report, include favorable reimbursement policies, increase in healthcare expenditure, increase in research and development activities for finding a cure for narcolepsy, extensive efforts undertaken by non-government and government organizations to spread awareness about narcolepsy, and growing demand for advanced therapies for sleeping disorders. Additional factors adding market growth include an increase in stress levels, rising cases of narcolepsy for an unhealthy lifestyle, and increasing awareness about sleep disorders.    On the cont...

Antipsychotic Drugs Market Anti-psychotics are drugs used in the treatment of psychosis which are a group of disorders characterized by serious distortion of thought, behavior, recognition of reality and perception, delusions and hallucinations. Antipsychotic Drugs Market is expected to register a CAGR of 5.7% to reach USD 33.59 Billion by 2030 The market for psychotics represents a huge potential as can be seen from the following estimates by World Health Organization (WHO) Depression affects an estimated 300 million people in the world. Bipolar affective disorder takes a toll on about 60 million people worldwide. Schizophrenia, a severe mental disorder, affects about 21 million people worldwide. Dementia has a prevalence in about 47.5 million people worldwide One fourth of people are affected by mental or neurological disorders at some point in their lives. Thus the current number of untapped patients are of an order of around 450 million. Other market drivers are ...

Obesity Managements Market The obesity management market size is projected to expand at 9.20% CAGR to reach USD 268.7 billion during the forecast period 2022-2030. According to World Health Organization (WHO), the worldwide prevalence of obesity nearly doubled between 1980 and 2008. According to country estimates for 2008, over 50% of both men and women in the WHO European Region were overweight, and roughly 23% of women and 20% of men were obese. It is the cause of many health problems, such as obesity, heart disease, and certain cancers. Obesity leads to short- and long-term health problems for mother and her child, if she is excess weight during pregnancy. Companies are continuously engaged in research and development process along with well know research institute for developing the best treatment of obesity and leads the market. In 2015, researchers at the University of Liverpool, working with a global health care company, have helped introduce a new treatment for obesity...

US Onychomycosis Market Onychomycosis is a contagious disease of the nails that causes staining, thickening, and partition from the nail bed. Onychomycosis happens in 10% of the all-inclusive population, 20% of people older than 60 years, and half of those older than 70 years. It is brought about by an assortment of organisms, however most cases are brought on by dermatophytes. The US Onychomycosis market is expected to reach high market figures by the end of the forecasted period and is expected to grow at a CAGR of 6.4% Major Key Players: Some of the US Onychomycosis Market Players are: Anacor Pharmaceuticals, Johnson and Johnson, Novartis, Valeant Pharmaceuticals Market Segmentation US Onychomycosis market has been segmented on the basis of types which comprises of distal subungual onychomycosis (dso), white superficial onychomycosis wso, proximal subungual onychomycosis (PSO), endonyx onychomycosis (EO), and others. Regional Analysis The report for US Onychomycosi...

Cystic Fibrosis Market Cystic fibrosis is a genetic disease that impacts the entire body turning on disability and causing death at an early age in many cases. It is mainly caused by mutations in the gene encoded as cystic fibrosis transmembrane conductance regulator (CFTR) protein. The report further encompasses segmental analysis, studies factors that can have far-reaching impacts, and introduces expert opinions to provide a comprehensive understanding of the market. The  Cystic Fibrosis Market  is expected to exhibit at 13.5% CAGR to reach USD 12.9 Billion over the forecast period 2023-2030 Increasing investment in the research and development for better drugs and therapies can take the cystic fibrosis market forward. At the same time, the Cystic Fibrosis Foundation (CFF) is spending in millions to aid the healthcare system. In the U.S., CFF has invested USD 425 million for the drug development of this particular disease which in itself is an affirmative step. As a re...

Pharmaceutical Excipients Market Pharmaceuticals are important components of a formulation that offers effective drug absorption. Excipients must comply with the regulatory requirements and must suit the intended dosage form. The compatibility is crucial in dosage forms that incorporate coating, controlled and sustained release, oil base (emulsifiers), and taste masking. The Pharmaceutical Excipients Market will witness a CAGR of 7.89 %, along with a value of USD 9.35 billion by 2030 in the forecast period. Excipients used in the manufacturing of drug serve as binders, disintegrants, glidants, or diluents. Therefore, multifunctional excipients can reduce the manufacturing cost and drug development of the product. Drivers and Restraints Owing to the patent expiries, the market has witnessed a robust growth rate in the recent times. Moreover, with the large patient population base and growing demand for pharmaceutical products will propel the growth of the market globally. ...